Get the Stockscreener App
1.26
5.26%
-0.07
After Hours:
1.26
Solesence Inc stock is traded at $1.26, with a volume of 57,851.
It is down -5.26% in the last 24 hours and up +4.13% over the past month.
Solesence Inc is a health-oriented, science-driven company, focused on various skin health, beauty and wellness markets. Its primary skin health products are fully developed prestige skin care formulations with mineral-based UV protection enabled by proprietary Active Pharmaceutical Ingredients, which are also marketed as APIs for sale to manufacturers of other types of skin health products, including sunscreens and daily care products. Additionally, it continues to sell products in legacy markets, including medical diagnostics, architectural coatings, industrial coating applications, abrasion-resistant additives, and plastics additives applications. The company operates as a single business segment.
See More
Previous Close:
$1.33
Open:
$1.37
24h Volume:
57,851
Relative Volume:
1.38
Market Cap:
$89.00M
Revenue:
$60.40M
Net Income/Loss:
$944.00K
P/E Ratio:
102.44
EPS:
0.0123
Net Cash Flow:
$-2.50M
1W Performance:
+5.00%
1M Performance:
+4.13%
6M Performance:
-37.62%
1Y Performance:
-69.04%
1-Day Range:
$1.24
$1.37
1-Week Range:
$1.10
$1.37
52-Week Range:
$0.78
$5.63
Solesence Inc Stock (SLSN) Company Profile
Name
Solesence Inc
Sector
Industry
Phone
(630) 771-6078
Address
1319 MARQUETTE DRIVE, ROMEOVILLE
Compare SLSN vs PG, UL, CL, KVUE, KMB
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLSN
Solesence Inc
|
1.26 | 93.94M | 60.40M | 944.00K | -2.50M | 0.0123 |
PG
Procter Gamble Co
|
150.46 | 348.38B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.69 | 127.59B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.58 | 71.58B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
18.25 | 34.83B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
103.14 | 33.95B | 16.56B | 1.75B | 1.84B | 6.36 |
Solesence Inc Stock (SLSN) Latest News
SLSN Q1 2026 Earnings: Narrowing Loss Amid Quiet QuarterEarnings Season Preview - newsline.com
Solesence Reports Record 62 Million Revenue For Fiscal Year 2025 - asatunews.co.id
Solesence (SLSN) Q4 2025 Earnings Transcript - AOL.com
Solesence Inc. (SLSN) Surges 7.32%: Testing Key Resistance at $1.39Strong Buy Stocks - newsline.com
SLSN Q1 2026 Earnings: Loss Per Share of -$0.01 as Shares Decline 2.34%Earnings Acceleration Picks - newsline.com
SLSN Q1 2026 Earnings: Narrowed Loss Amidst Operational UncertaintyNew Analyst Coverage - The Legal Advocate
SLSN Q1 2026 Earnings: Narrowing Loss Amid TransitionEBITDA Analysis - Newser
SLSN Q1 2026 Earnings: Narrow Loss Reported Amid Quiet QuarterLong-Term Guidance - The Legal Advocate
Solesence targets 30% gross margin floor while aiming to return to double-digit EBITDA margins by year-end 2026 - MSN
Solesence, Inc. Navigates Transitional Quarter on Earnings - The Globe and Mail
Solésence, Inc. Day Mode Hero Concealer Wins Three Awards at 2026 C&T Allē Awards for Anti-Aging, Color Cosmetics, and Compromised Skin - Quiver Quantitative
Solésence Day Mode Hero Concealer SPF 50+ Wins Three - GlobeNewswire
SPF 50+ concealer wins three anti-aging, color and compromised skin awards - Stock Titan
SLSN Incurs Q1 Loss Due to Shipment Delays, High Operating Costs - TradingView
Solesence (SLSN) Q1 2026 Earnings Transcript - AOL.com
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition - The Manila Times
Solésence, Inc. Supports APPG Report Advocating for National UV Safety Strategy in the UK - Quiver Quantitative
Solesence (SLSN) Drops -2.65% — Key Support at $1.22 2026-05-14Analyst Upgrade - newser.com
UK warned on UV cancer risk as Solésence backs safety drive - Stock Titan
Solesence, Inc. Charts Cautious Course After Tough Quarter - The Globe and Mail
Solesence Inc (SLSN) Q1 2026 Earnings Call Highlights: Navigatin - GuruFocus
Solesence, Inc. Common Stock Q1 2026 Earnings Call Summary - Yahoo Finance
Solesence 1Q Rev $13M >SLSN - Moomoo
Solésence (NASDAQ: SLSN) swings to Q1 2026 loss on lower sales - Stock Titan
Solesence, Inc.Common stock (Nasdaq:SLSN) Stock Quote - The Chronicle-Journal
Solésence, Inc. Announces Q1 2026 Financial Results and Progress on Transform & Transcend Initiative - Minichart
Solesence, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Is Solesence (SLSN) 17.6% Undervalued After Q1 2026? Revenue $13 - GuruFocus
Earnings call transcript: Solesence Q1 2026 sees revenue dip, stock falls - Investing.com
SLSN Insider Trade: CFO Riffner Sells 60K Shares May 12, 2026 - Meyka
Solesence Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Solésence (NASDAQ: SLSN) Q1 2026 revenue falls to $13M, swings to loss - Stock Titan
Solésence Reports First Quarter 2026 Financial Results - The Manila Times
Solesence 1Q Loss/Shr 1c >SLSN - Moomoo
Solésence launches two cosmetics ingredient platforms By Investing.com - Investing.com South Africa
Solésence launches two cosmetics ingredient platforms - Investing.com
Solésence, Inc Announces Commercial Availability Of WHSPR? and Chromalüm? - marketscreener.com
SLSN Solesence revenue jumps 18.6% year-over-year in Q1, driving shares 3.85% higher amid investor optimism.Current Ratio - newser.com
SLSN Insider Trade: CFO Riffner Sells 60K Shares May 08, 2026 - Meyka
SLSN Insider Trade: CFO Riffner Sells 60K Shares May 04, 2026 - Meyka
What Solesence (SLSN) bond yields suggest about risk |Strong Momentum - newser.com
Solesence Inc Stock (SLSN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Solesence Inc Stock (SLSN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| WHITMORE R JANET | Director |
Nov 14 '25 |
Buy |
1.73 |
19,789 |
34,235 |
2,068,931 |
| WHITMORE R JANET | Director |
Nov 19 '25 |
Buy |
1.92 |
10,000 |
19,200 |
2,084,198 |
| WHITMORE R JANET | Director |
Nov 17 '25 |
Buy |
1.87 |
5,000 |
9,350 |
2,073,931 |
| WHITMORE R JANET | Director |
Nov 18 '25 |
Buy |
1.83 |
267 |
489 |
2,074,198 |
2.32%
4.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):